Periprosthetic Infection Due to Resistant Staphylococci: Serious Problems on the Horizon


Creative Commons License

Parvizi J., Azzam K., Ghanem E., Austin M. S., Rothman R. H.

CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, cilt.467, sa.7, ss.1732-1739, 2009 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 467 Sayı: 7
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1007/s11999-009-0857-z
  • Dergi Adı: CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1732-1739
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Prosthetic joint infections (PJI) caused by methicillin-resistant staphylococci represent a major therapeutic challenge. We examined the effectiveness of surgical treatment in treating infection of total hip or knee arthroplasty caused by methicillin-resistant staphylococcal strains and the variables influencing treatment success. One hundred and twenty-seven patients were treated at our institution between 1999 and 2006. There were 58 men and 69 women, with an average age of 66 years. Patients were followed for a minimum of 2 years or until recurrence of infection. D,bridement and retention of the prosthesis was performed in 35 patients and resection arthroplasty in 92. D,bridement controlled the infection in only 37% of cases whereas two-stage exchange arthroplasty controlled the infection in 75% of hips and 60% of knees. Preexisting cardiac disease was associated with a higher likelihood of failure to control infection in all treatment groups. Antibiotic-resistant Staphylococci continue to compromise treatment outcome of prosthetic joint infections, especially in patients with medical comorbidities. New preventive and therapeutic strategies are needed. Level of Evidence: Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.